Live Breaking News & Updates on Jake Simson|Page 2
Stay updated with breaking news from Jake simson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Vivace Therapeutics Announces $30 Million Series C Financing to Fund Clinical Programs Targeting the Hippo Pathway News provided by Share this article Share this article SAN MATEO, Calif., Dec. 16, 2020 /PRNewswire/ Vivace Therapeutics, Inc., a small molecule discovery and development company developing first-in-class therapies targeting the Hippo pathway, announced today the closing of a $30 million Series C financing. The company anticipates advancing its clinical candidate into first-in-human studies in early 2021, targeting tumors dependent on activated YAP. The Series C financing was led by Boxer Capital with participation from new investor RA Capital Management alongside existing investor Canaan Partners. With the financing, Dr. Norman Zhou of Boxer Capital has joined the board of directors at Vivace. ....